Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has a cash flow conversion efficiency ratio of 0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥9.12 Million ≈ $1.33 Million USD) by net assets (CN¥910.35 Million ≈ $133.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Shenzhen Bioeasy Biotechnology Co. Ltd. market capitalisation for the company's overall valuation and market capitalisation.
Shenzhen Bioeasy Biotechnology Co. Ltd. - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Shenzhen Bioeasy Biotechnology Co. Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Shenzhen Bioeasy Biotechnology Co. Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shenzhen Bioeasy Biotechnology Co. Ltd. ranked by their cash flow conversion efficiency. Explore Shenzhen Bioeasy Biotechnology Co. Ltd. cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Pes Camanchaca
SN:CAMANCHACA
|
0.052x |
|
Barnes & Noble Education Inc
NYSE:BNED
|
0.274x |
|
Chieftek Precision Co Ltd
TW:1597
|
0.051x |
|
Reckitt Benckiser Group PLC
LSE:RKT
|
0.108x |
|
Long Yuan Construction Group Co Ltd
SHG:600491
|
0.027x |
|
Lontrue Co Ltd
SHE:300175
|
-0.111x |
|
Dufu Tech Corp Bhd
KLSE:7233
|
-0.004x |
|
PGIM Short Duration High Yield Opportunities Fund
NYSE:SDHY
|
N/A |
Annual Cash Flow Conversion Efficiency for Shenzhen Bioeasy Biotechnology Co. Ltd. (2016–2025)
The table below shows the annual cash flow conversion efficiency of Shenzhen Bioeasy Biotechnology Co. Ltd. from 2016 to 2025. View latest Shenzhen Bioeasy Biotechnology Co. Ltd. stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥907.68 Million ≈ $132.82 Million |
CN¥66.87 Million ≈ $9.79 Million |
0.074x | +87.15% |
| 2024-12-31 | CN¥870.24 Million ≈ $127.34 Million |
CN¥34.26 Million ≈ $5.01 Million |
0.039x | +189.70% |
| 2023-12-31 | CN¥848.73 Million ≈ $124.20 Million |
CN¥-37.25 Million ≈ $-5.45 Million |
-0.044x | -127.75% |
| 2022-12-31 | CN¥964.70 Million ≈ $141.17 Million |
CN¥152.55 Million ≈ $22.32 Million |
0.158x | -41.40% |
| 2021-12-31 | CN¥946.58 Million ≈ $138.51 Million |
CN¥255.42 Million ≈ $37.38 Million |
0.270x | +132.21% |
| 2020-12-31 | CN¥548.98 Million ≈ $80.33 Million |
CN¥63.79 Million ≈ $9.34 Million |
0.116x | -8.70% |
| 2019-12-31 | CN¥528.32 Million ≈ $77.31 Million |
CN¥67.24 Million ≈ $9.84 Million |
0.127x | -51.09% |
| 2018-12-31 | CN¥222.62 Million ≈ $32.58 Million |
CN¥57.93 Million ≈ $8.48 Million |
0.260x | +26.35% |
| 2017-12-31 | CN¥114.60 Million ≈ $16.77 Million |
CN¥23.60 Million ≈ $3.45 Million |
0.206x | -68.67% |
| 2016-12-31 | CN¥55.24 Million ≈ $8.08 Million |
CN¥36.31 Million ≈ $5.31 Million |
0.657x | -- |
About Shenzhen Bioeasy Biotechnology Co. Ltd.
Shenzhen Bioeasy Biotechnology Co., Ltd., together with its subsidiaries, provides rapid food testing reagents and instruments in China and internationally. The company offers test kits, including veterinary, melamine, mycotoxin, pesticide, adulteration, ATP, vitamin, and others; equipment, such as incubator, reader, suitcase lab, automatic pressers, and others; and materials comprising pretreatm… Read more